IDH2 and acute myeloid leukemia: The authors found no second-site IDH2 mutations but reported seven different patterns of clonal evolution, including mutations of IDH1, cytokine receptor signaling genes, hematopoietic transcription factors, components of the spliceosome, and chromosome 7 monosomy, which restored the differentiation blockade in AML cells [122].